NCT03267030 2024-03-15
Asparaginase Encapsulated in Erythrocytes for Patients With ALL and Hypersensitivity to PEG-asparaginase
Aarhus University Hospital
Phase 2 Completed
Clinical Trials
5 trialsNCT03665441 2022-10-18
Trybeca-1
ERYtech Pharma
Phase 3 Completed
NCT03674242 2022-08-01
Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone for the Treatment of TNBC (TRYbeCA-2)
ERYtech Pharma
Phase 2/3 Terminated
NCT01810705 2022-02-21
ENFORCE
ERYtech Pharma
Phase 2 Completed
NCT02197650 2018-12-04
EAP
ERYtech Pharma
No longer available